Search





Search





Markets
/
Stocks
/
antx
/

AN2 Therapeutics Inc

ANTX

Add to Watchlist

4.920USD

0.0000.00%

Close 07-24 16:00（ET）Quotes delayed by 15 min

134.67MMarket Cap

LossP/E TTM

AN2 Therapeutics Inc

4.920

0.0000.00%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ANTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of AN2 Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-13.64%-12.07M

0.70%-5.24M

46.91%-6.38M

47.17%-7.60M

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Net income from continuing operations

5.83%-10.03M

-15.79%-8.71M

26.63%-9.35M

55.23%-6.46M

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-100.17%-15.32M

---11.84M

---11.34M

---10.12M

---7.66M

Other non-cash items

81.72%-81.00K

79.37%-117.00K

71.14%-211.00K

66.40%-299.00K

59.40%-443.00K

56.58%-567.00K

-14.22%-731.00K

-102.27%-890.00K

-162.26%-1.09M

-267.89%-1.31M

-184.44%-640.00K

-730.19%-440.00K

-2289.47%-416.00K

---355.00K

---225.00K

---53.00K

--19.00K

Change in working capital

-116.85%-3.42M

111.49%2.19M

654.06%2.39M

-113.23%-2.84M

30.44%-1.58M

194.53%1.04M

-112.76%-431.00K

-190.05%-1.33M

-209.40%-2.27M

-135.50%-1.10M

297.88%3.38M

322.44%1.48M

366.29%2.08M

--3.09M

--849.00K

---664.00K

--445.00K

-Change in prepaid expenses

-141.40%-267.00K

-80.49%159.00K

880.43%2.51M

-127.04%-1.80M

-41.84%645.00K

231.24%815.00K

-1633.33%-322.00K

31.93%-795.00K

49.46%1.11M

-159.03%-621.00K

-96.69%21.00K

43.82%-1.17M

231.10%742.00K

--1.05M

--634.00K

---2.08M

---566.00K

-Change in other current assets

----

---720.00K

----

-Change in other current liabilities

-56.87%-662.00K

351.24%1.22M

-174.48%-534.00K

45.61%348.00K

-21.97%-422.00K

-57.65%-484.00K

-26.31%717.00K

--239.00K

---346.00K

---307.00K

--973.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-13.64%-12.07M

0.70%-5.24M

46.91%-6.38M

47.17%-7.60M

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Investing cash flow

Net cash flow from investment products

-9.82%8.29M

204.27%7.17M

-67.36%6.11M

-64.56%5.83M

-65.03%9.19M

-1738.10%-6.88M

129.97%18.72M

108.96%16.46M

141.48%26.29M

-93.06%420.00K

-2595.81%-62.46M

119.95%7.88M

-22.11%10.89M

--6.05M

---2.32M

---39.49M

--13.98M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-9.82%8.29M

204.27%7.17M

-67.36%6.11M

-64.56%5.83M

-65.03%9.19M

-1738.10%-6.88M

129.97%18.72M

108.96%16.46M

141.48%26.29M

-93.06%420.00K

-2595.81%-62.46M

119.95%7.88M

-22.11%10.89M

--6.05M

---2.32M

---39.49M

--13.98M

Financing cash flow

Cash flow from continuous financing activities

57329.23%37.33M

--0.00

108.70%48.00K

--0.00

-81.38%65.00K

100.00%0.00

-99.97%23.00K

-100.00%0.00

75.38%349.00K

---321.00K

660760.00%66.07M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.19M

Net cash flow from common stock issuance/repurchase

57618.42%21.93M

--0.00

108.70%48.00K

--0.00

-69.35%38.00K

--0.00

-99.97%23.00K

-100.00%0.00

-37.69%124.00K

--0.00

659770.00%65.97M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.20M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

Proceeds from stock option exercised by employees

-11.11%24.00K

--0.00

-88.00%27.00K

--0.00

-100.00%0.00

--0.00

--225.00K

--0.00

--99.00K

--0.00

100.00%0.00

--0.00

---11.00K

Proceeds from issuance of warrants

--15.37M

----

Net cash flow from other financing activities

--37.27M

--0.00

----

---321.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

57329.23%37.33M

--0.00

108.70%48.00K

--0.00

-81.38%65.00K

100.00%0.00

-99.97%23.00K

-100.00%0.00

75.38%349.00K

---321.00K

660760.00%66.07M

165.39%19.05M

-99.69%199.00K

--0.00

---10.00K

--7.18M

--63.19M

Net cash flow

Beginning cash balance

-6.60%19.94M

-46.27%18.00M

-31.94%18.22M

-19.07%19.98M

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

125.01%27.22M

--28.80M

--40.62M

--82.52M

--12.10M

Current period cash flow changes

2555.78%33.55M

115.95%1.94M

-103.22%-217.00K

-185.02%-1.76M

-115.10%-1.37M

28.38%-12.15M

182.17%6.74M

-85.28%2.08M

1873.73%9.05M

-971.95%-16.97M

30.62%-8.20M

133.66%14.10M

-100.72%-510.00K

---1.58M

---11.81M

---41.90M

--70.42M

Ending cash balance

167.64%53.49M

-6.60%19.94M

-46.27%18.00M

-31.94%18.22M

-19.07%19.98M

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

--27.22M

--28.80M

--40.62M

--82.52M

Free cash flow

-13.64%-12.07M

0.70%-5.24M

46.91%-6.38M

47.17%-7.60M

39.61%-10.62M

69.11%-5.27M

-1.75%-12.01M

-12.16%-14.38M

-51.72%-17.59M

-123.46%-17.07M

-24.38%-11.80M

-33.65%-12.82M

-72.00%-11.60M

---7.64M

---9.49M

---9.60M

---6.74M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did AN2 Therapeutics Inc Generate?



AN2 Therapeutics Inc generated -29.83M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did AN2 Therapeutics Inc's Operating Cash Flow Change Year Over Year?



AN2 Therapeutics Inc's operating cash flow increased by 39.43% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has AN2 Therapeutics Inc's Financing Cash Flow Changed?



AN2 Therapeutics Inc used 113.00K in financing activities in the latest quarter.

What is free cash flow and why does it matter for ANTX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was AN2 Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -29.83M reflecting a 39.43% change from the previous year.